The primary HS code utilized for Citalopram is 30049099, which pertains to "Other medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale." This code is widely adopted across various markets, including Morocco, the United States, Belgium, Brazil, Canada, Australia, the United Kingdom, and South Africa.
Morocco: According to the World Trade Organization (WTO) tariff database, Morocco applies a Most Favored Nation (MFN) tariff rate of 2.5% on products classified under HS code 30049099. Morocco and India have a Preferential Trade Agreement (PTA) that may offer reduced tariffs on pharmaceutical products; however, specific preferential rates for Citalopram should be verified with Moroccan customs authorities. Essential medicines may be subject to exemptions or reduced tariffs, contingent upon national health policies.
United States: The U.S. International Trade Commission (USITC) indicates that the MFN tariff rate for HS code 30049099 is 0%. The United States does not have a Free Trade Agreement (FTA) with India that affects this tariff line. Essential medicines are generally exempt from tariffs, aligning with public health objectives.
Belgium: As a member of the European Union (EU), Belgium applies the EU's Common External Tariff. The MFN tariff rate for HS code 30049099 is 0%. The EU-India Trade Agreement, currently under negotiation, may influence future tariff rates. Essential medicines are typically exempt from tariffs within the EU.
Brazil: The WTO tariff database reports that Brazil imposes an MFN tariff rate of 8% on HS code 30049099. Brazil and India are both members of the MERCOSUR-India Preferential Trade Agreement, which may offer reduced tariffs on certain pharmaceutical products. Essential medicines may benefit from exemptions or lower tariffs, subject to Brazilian health regulations.
